GlassScriptPhysician profile
Jeffrey Carson Hagedorn
NPI 1679529879
$2,893.02
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,127 · 2020: $348 · 2021: $272 · 2022: $146.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $630.62 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $328.21 | 2019-2020 | |
| Emd Serono, INC. | $208.02 | 2019-2020 | |
| Eisai INC. | $177.51 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $175.47 | 2019-2020 | |
| Genzyme Corporation | $169.90 | 2019-2020 | |
| Biogen, INC. | $140.78 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $115.12 | 2019 | |
| Genentech USA, INC. | $109.53 | 2019 | |
| Sunovion Pharmaceuticals INC. | $109.30 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $91.87 | 2019-2021 | |
| Abbvie INC. | $78.11 | 2019-2022 | |
| Greenwich Biosciences, INC. | $60.80 | 2019 | |
| Jazz Pharmaceuticals INC. | $53.33 | 2019-2020 | |
| Lilly USA, LLC | $48.63 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $47.57 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $43.71 | 2020 | |
| Neurocrine Biosciences, INC. | $39.75 | 2019 | |
| Adamas Pharmaceuticals, INC. | $25.83 | 2019 | |
| Banner Life Sciences, LLC | $25.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $24.80 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $24.62 | 2022 | |
| Pfizer INC. | $23.84 | 2019 | |
| Harmony Biosciences LLC | $21.40 | 2020 | |
| Amgen INC. | $20.37 | 2020 | |
| Ge Healthcare | $19.41 | 2019 | |
| Mdd US Operations, LLC | $16.68 | 2022 | |
| Vertical Pharmaceuticals, LLC | $16.64 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $15.98 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.38 | 2022 | |
| Sk Life Science, INC. | $14.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Hagedorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.